While the prevalence of opioid use disorder (OUD) among pregnant women has multiplied in the United States in the last decade. buprenorphine treatment (BT) for peripartum women with OUD has been administered to reduce risks of repeated cycles of craving and withdrawal. However. the maternal behavior and bonding in mothers with OUD may be altered as the underlying maternal behavior neu... https://www.chiggate.com/shades-eq-gloss-07m-driftwood-for-sale/